Table 4 Cardiovascular risk factors in a random subgroup (n = 11,418) of Golestan Cohort Study participants according to blood group phenotype
From: Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study
Variable | Blood group | ||||
|---|---|---|---|---|---|
|  | O (number = 3,489) | A (number = 3,738) | B (number = 3,089) | AB (number = 1,102) | Non-O (number = 7,929) |
Total cholesterol a | 202.9 (43.5) | 205.6 (43.8)** | 200.5 (41.7)* | 201.0 (41.3) | 203.0 (42.7) |
HDL | 59.4 (14.8) | 59.9 (14.8) | 59.2 (14.4) | 59.1 (14.5) | 59.5 (14.6) |
LDL | 116.2 (36.1) | 118.8 (35.4)** | 114.2 (34.4)* | 115.9 (34.5) | 116.6 (35.0) |
Triglycerides | 139.8 (98.3) | 139.2 (102.0) | 139.3 (98.9) | 132.3 (77.9)* | 138.3 (97.8) |
FBG | 103.7 (39.5) | 105.6 (41.1) | 104.8 (40.7) | 106.0 (45.3)* | 105.4 (41.6)* |
Systolic blood pressure | 125.8 (20.9) | 125.7 (20.6) | 125.7 (21.0) | 124.9 (20.5) | 125.6 (20.8) |
Diastolic blood pressure | 77.8 (12.5) | 77.4 (12.5) | 77.5 (12.6) | 77.7 (12.4) | 77.5 (12.5) |
BMI | 27.1 (5.3) | 27.1 (5.3) | 27.1 (5.4) | 27.0 (5.3) | 27.1 (5.3) |
Waist circumference | 94.6 (13.8) | 94.6 (13.8) | 94.6 (14.1) | 94.2 (14.0) | 94.5 (13.9) |